Dr. Yan Xia is Head of Nanotechnology Formulations, overseeing LNP programs for nucleic acid delivery. Prior to Axelyf, Yan served as Scientific Director of Platform Delivery at 76Bio, leading LNP discovery efforts for extrahepatic delivery of novel targeted protein degraders. Previously, she spent nearly seven years at Moderna and has made significant contributions to the development of biophysical tools for LNP characterization as well as fundamental understanding of LNP structure-activity relationship.

Yan holds a Ph.D. in Chemical Engineering from University of Connecticut, and B.E. in Light Chemical Engineering from Sichuan University, Chengdu, China.